Awarded contract

Pharmaceutical products

Details

Buyer
NHS England
Supplier(s)
36 suppliers
Value
GBP 643,563,034
Topic
Pharmaceutical products
Published
23 February 2021
Source
TedNotices

Tender description

CM/PHR/20/5591/01 — Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months CM/PHR/20/5591/02 — Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months CM/PHR/20/5591/03 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021 CM/PHR/20/5591/04 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021. CM/PHR/20/5591/01 — NHS Framework for the Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5591/02 — NHS Framework for the Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5591/03 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021. CM/PHR/20/5591/04 – NHS framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021.

Timeline

  1. Award date25 January 2021
  2. Award published23 February 2021
    Current notice

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to Pharmaceutical products.

Explore all open tenders

Related buyers

Buyers similar to NHS England.

View all buyers
BuyersCountValue
  1. NHS Property Services Ltd
    461
    £2.1bn
  2. UK Shared Business Services - UKSBS
    374
    £250.3m
  3. Sellafield Limited
    366
    £15.0bn
  4. Bank of England
    298
    £2.8bn
  5. Network Rail
    267
    £19.9bn
  6. Department of Health and Social Care
    266
    £903.0m
  7. Financial Conduct Authority
    255
    £517.2m
  8. Post Office Ltd
    203
    £1.0bn
  9. Nuclear Decommissioning Authority (NDA)
    143
    £900.1m
  10. Genomics England
    135
    £63.9m

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.

Try for free